| (84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
Designated Extension States: |
|
AL LT LV MK RO SI |
| (30) |
Priority: |
11.05.1998 EP 98500117
18.09.1998 EP 98500204
|
| (71) |
Applicant: Glaxo Wellcome S.A. |
|
28760 Tres Cantos (ES) |
|
| (72) |
Inventors: |
|
- BUENO, Jose M.,Glaxo Wellcome S.A.
E-28760 Tres Cantos (ES)
- CHICHARRO GONZALO, Jesus,Glaxo Wellcome S.A.
E-28760 Tres Cantos (ES)
- COTERON, Jose-Miguel,Glaxo Wellcome S.A.
E-28760 Tres Cantos (ES)
- CUEVAS, Juan Carlos,Glaxo Wellcome S.A.
E-28760 Tres Cantos (ES)
- FIANDOR, Jose M.,Glaxo Wellcome S.A.
E-28760 Tres Cantos (ES)
- MALLO, Araceli,Glaxo Wellcome S.A.
E-28760 Tres Cantos (ES)
|
| (74) |
Representative: Filler, Wendy Anne, Dr. et al |
|
Glaxo Wellcome plcGlaxo Wellcome House,Berkeley Avenue
Greenford, Middlesex UB6 0NN
Greenford, Middlesex UB6 0NN (GB) |
|
